Frontlight ResearchEarly access
Active, not recruitingNo phase
Epigenetic Profiling and Liquid Biopsy: Perspectives for Personalized Medicine in Meningioma Patients - MIND
Key facts
- Who runs it
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 210 people, planned
- Started
- 25 Sept 2024
- Expected to end
- Dec 2026
- Type of study
- Observational, 2 groups
- Record updated
- 28 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Patient aged 18 years or older
- First diagnosis of uni-focal meningioma of the convexity
- Macroscopical total resection (Simpson 1-3); (Retrospective only):
- Surgery performed between 2007 and 2016
- availability of FFPE sample and medical records
Who cannot take part
- Previous surgical/medical treatment for another meningioma
- Genetic syndromes
- positive oncological history (e.g., breast cancer)
- Diffuse Meningeal Meningiomatosis
- Patients who underwent experimental treatment in neo-adjuvant setting; (Prospective only):
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Meningiomas are the most common primary intracranial tumors. Current treatment relies on surgical resection and radiotherapy, but molecular predictors for recurrence are lacking. This study aims to investigate epigenetic features, specifically histone post-translational modifications (PTMs) and DNA methylation, to stratify patients. The study involves a retrospective cohort to define an epigenetic signature and a prospective cohort to validate it in tissues and liquid biopsies (plasma/EVs).
The 2 groups in the trial
- Retrospective Cohort
150 patients operated for non-recurrent meningioma between 2008 and 2016.
- Prospective Cohort
60 patients diagnosed with meningioma recruited prospectively.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Epigenetic Profiling and Liquid Biopsy: Perspectives for Personalized Medicine in Meningioma Patients
- Record updated
- 28 August 2026